Understanding the Feasibility, Acceptability, and Efficacy of a Clinical Pharmacist-led Mobile Approach (BPTrack) to Hypertension Management: Mixed Methods Pilot Study

Abstract

Background Hypertension is a prevalent and costly burden in the United States. Clinical pharmacists within care teams provide effective management of hypertension, as does home blood pressure monitoring; however, concerns about data quality and latency are widespread. One approach to close the gap between clinical pharmacist intervention and home blood pressure monitoring is the use of mobile health (mHealth) technology. Objective We sought to investigate the feasibility, acceptability, and preliminary effectiveness of BPTrack, a clinical pharmacist-led intervention that incorporates patient- and clinician-facing apps to make electronically collected, patient-generated data available to providers in real time for hypertension management. The patient app also included customizable daily medication reminders and educational messages. Additionally, this study sought to understand barriers to adoption and areas for improvement identified by key stakeholders, so more widespread use of such interventions may be achieved. Methods We conducted a mixed methods pilot study of BPTrack, to improve blood pressure control in patients with uncontrolled hypertension through a 12-week pre-post intervention. All patients were recruited from a primary care setting where they worked with a clinical pharmacist for hypertension management. Participants completed a baseline visit, then spent 12 weeks utilizing BPTrack before returning to the clinic for follow-up. Collected data from patient participants included surveys pre- and postintervention, clinical measures (for establishing effectiveness, with the primary outcome being a change in blood pressure and the secondary outcome being a change in medication adherence), utilization of the BPTrack app, interviews at follow-up, and chart review. We also conducted interviews with key stakeholders. Results A total of 15 patient participants were included (13 remained through follow-up for an 86.7% retention rate) in a single group, pre-post assessment pilot study. Data supported the hypothesis that BPTrack was feasible and acceptable for use by patient and provider participants and was effective at reducing patient blood pressure. At the 12-week follow-up, patients exhibited significant reductions in both systolic blood pressure (baseline mean 137.3 mm Hg, SD 11.1 mm Hg; follow-up mean 131.0 mm Hg, SD 9.9 mm Hg; P=.02) and diastolic blood pressure (baseline mean 89.4 mm Hg, SD 7.7 mm Hg; follow-up mean 82.5 mm Hg, SD 8.2 mm Hg; P<.001). On average, patients uploaded at least one blood pressure measurement on 75% (SD 25%) of study days. No improvements in medication adherence were noted. Interview data revealed areas of improvement and refinement for the patient experience. Furthermore, stakeholders require integration into the electronic health record and a modified clinical workflow for BPTrack to be truly useful; however, both patients and stakeholders perceived benefits of BPTrack when used within the context of a clinical relationship. Conclusions Results demonstrate that a pharmacist-led mHealth intervention promoting home blood pressure monitoring and clinical pharmacist management of hypertension can be effective at reducing blood pressure in primary care patients with uncontrolled hypertension. Our data also support the feasibility and acceptability of these types of interventions for patients and providers. Trial Registration ClinicalTrials.gov NCT02898584; https://clinicaltrials.gov/ct2/show/NCT02898584 International Registered Report Identifier (IRRID) RR2-10.2196/resprot.8059

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

“…Telehealth facilitates more engaging and efficient management of chronic conditions and allows members of the patient care team, such as pharmacists to connect with patients and thereby improve patient outcomes 5,7‐9 . Telehealth interventions by pharmacists can improve the control of blood pressure and reduce serum levels of hemoglobin A1c when compared with the usual standard of care afforded by primary care providers alone 8,10,11 …”

Factors Affecting Self-Care Among Hypertensive Older Adults Dwelling in the Community: A Cross-Sectional Study

“…(2020) [35], continuous blood pressure monitoring at home with data entry into a mobile machine and the provision of personalized interventions were effective in controlling blood pressure levels. Thus, a national health care approach that provides home blood pressure monitors can be explored.…”

Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions

“…Other meta-analyses confirmed reductions in SBP for text messaging interventions (mean difference = −6.1, 95% CI −8.5, −3.8, P < 0.01) [13 ▪ ], and smartphone applications (weighted mean difference = −2.28, 95% CI −3.90, −0.66, P = 0.006) [17]. Individual studies demonstrated a 6.7 mmHg greater reduction in SBP in a tailored mobile-application intervention versus control ( P = 0.10) [16 ▪ ], declines in both SBP (baseline mean 137.3 mm Hg, standard deviation (SD) 11.1, follow-up mean 131.0 mm Hg, SD 9.9, P = 0.02) and DBP (baseline mean 89.4 mm Hg, SD 7.7, follow-up mean 82.5 mm Hg, SD 8.2, P < 0.001) after a 12-week pharmacist-led telehealth intervention [9], and increased odds of BP control associated with tailored monthly phone counseling matched to a patient's stage of change (OR = 1.84, 95% CI 1.28, 2.67, P = 0.001) versus usual care AND monthly phone counseling using nontailored information (OR = 1.48, 95% CI 1.02, 2.14, P = 0.04) versus usual care [19].…”

“…Some studies report provider perspectives on eHealth strategies, documenting concerns about the quality of self-monitored data [9,27 ▪ ] and who holds responsibility for self-monitored clinical data [10]. Implementing eHealth interventions to improve adherence requires training, monitoring, and action on the part of healthcare providers and staff to encourage patient participation and resolve technical issues; the future of insurance reimbursement to support this effort is unclear [27 ▪ ].…”

“…By promoting flexibility and convenience and minimizing access barriers associated with in-person contact [3 ▪▪ ,5 ▪▪ ,7], eHealth strategies can enable ready access to tailored information, timely assessment, and prompt consultation [4 ▪▪ ,5 ▪▪ ,8], while empowering and engaging patients in their own healthcare and encouraging patient–provider collaboration [3 ▪▪ ,4 ▪▪ ,5 ▪▪ ,8,9]. Yet, challenges and knowledge gaps regarding patient engagement and burden, sustainability, and equitable access remain [3 ▪▪ ,5 ▪▪ ,8–11]. Understanding the effects of eHealth over time and across sociodemographic groups is critical to appreciating and harnessing its potential.…”